Holocene Advisors, LP Argenx Se Transaction History
Holocene Advisors, LP
- $22.9 Billion
- Q3 2024
A detailed history of Holocene Advisors, LP transactions in Argenx Se stock. As of the latest transaction made, Holocene Advisors, LP holds 195,104 shares of ARGX stock, worth $122 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
195,104
Previous 425,614
54.16%
Holding current value
$122 Million
Previous $183 Million
42.19%
% of portfolio
0.46%
Previous 0.81%
Shares
12 transactions
Others Institutions Holding ARGX
# of Institutions
400Shares Held
30.9MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.63 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.19 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.55 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$1.06 Billion0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$773 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $34.5B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...